Royal Bank of Canada
CARL

Royal Bank of Canada’s Carlsmed CARL Stock Holding History

Royal Bank of Canada’s Portfolio CARL Stock Details CARL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5K Sell
572
-454
-44% -$5.49K ﹤0.01% 6455
2025
Q4 		$13K Buy
1,026
+960
+1,455% +$12.8K ﹤0.01% 6307
2025
Q3 		$0 Buy
+66
New +$902 ﹤0.01% 7687

Other funds holding CARL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KC
KCM Capital Shawnee, Kansas $622M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada's CARL Position: Q1 2026 in Review

Royal Bank of Canada reduced its Carlsmed (CARL) stake by 44% in Q1 2026, selling an estimated $5.49K and leaving 572 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #6455.

Royal Bank of Canada first reported a position in CARL in Q3 2025 and has held it in 3 quarters since. The position peaked at $13K in Q4 2025. 66 funds tracked by Wall St. Rank hold CARL as of Q1 2026.

  • Royal Bank of Canada held 572 shares of Carlsmed worth $5K as of Q1 2026.
  • Royal Bank of Canada sold 454 Carlsmed shares in Q1 2026, an estimated $5.49K.
  • Carlsmed made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6455 holding.
  • Royal Bank of Canada first reported a position in Carlsmed in Q3 2025 and has held it in 3 quarters since.
  • Royal Bank of Canada's Carlsmed position peaked at $13K in Q4 2025.
  • 66 funds tracked by Wall St. Rank held Carlsmed as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.